Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista Española de Enfermedades Digestivas
versión impresa ISSN 1130-0108
Resumen
DIAZ SIBAJA, M. A.; COMECHE MORENO, M. I. y MAS HESSE, B.. Protocolized cognitive-behavioural group therapy for inflammatory bowel disease. Rev. esp. enferm. dig. [online]. 2007, vol.99, n.10, pp.593-598. ISSN 1130-0108.
Introduction: patients affected by inflammatory bowel disease have a high rate of psychiatric disorders such as depression and anxiety. Objective: the main goal of this study was to design, to put into practice, and to validate a protocolized psychological treatment program based on the coping model, and a psycho-educational methodology in which the following intervention modules were included- illness information, coping model, problem solving techniques, relaxation, social skill training, distraction, and cognitive restructuring techniques. All these techniques were adapted to the characteristic features of inflammatory bowel disease. Method: the sample included 57 patients with inflammatory bowel disease from the Spanish Crohn's Disease and Ulcerative Colitis Association. The sample was randomly assigned to one of the two experimental groups -33 were assigned to the treatment group, and 24 were assigned to the waiting list control group. Results: the results reflected a significant clinical and statistical improvement in anxiety (p < 0.001) and depression (p < 0.001) variables when compared to the waiting list control group. Likewise, improvement was sustained at 3, 6, and 12 months during follow-up. Conclusion: the protocolized psychological treatment program, administered in group sessions, is effective in reducing emotional symptoms arising as a result of inflammatory bowel disease.
Palabras clave : Inflammatory bowel disease; Cognitive-behavioural therapy; Protocolized treatment; Multi-component psychological treatment program; Crohn's disease and ulcerative colitis.